Nervous Control of Blood Vessel Diameter:
Blood vessels receive sympathetic
innervation
The neurotransmitter involved is
There is always some tonic activity
At baseline, there is a certain frequency of the impulses which maintains
If you increase the nerve traffic then you can constrict the vessel If you decrease the nerve traffic then you can dilate the vessel
Cardiac innervation:
We change the heart rate by dual innervation - sympathetic and parasympathetic
The sinoatrial nodal cells receive sympathetic and parasympathetic innervation
Normal resting heart rate is around
Parasympathetic slows heart rate down because
decreases the gradient of the pacemaker potential - this means that the potential takes longer to reach threshold and fire
Sympathetic increases heart rate because
and noradrenaline increases the gradient of the pacemaker potential so threshold is reached more quickly
If we cut the sympathetic nerves we lose the ability to increase heart rate so heart rate falls
Controlling Force of Contraction:
Force of contraction can be increased by Starling's Law.Sympathetic activity will also increase the force of contraction
Noradrenaline binds to Adrenoreceptors which increases the amount of
which activates PKA which phosphorylates the L-type calcium channels and the SR calcium release channel and SERCA
So you get more calcium influx and more calcium taken back up into the stores
Action of noradrenaline on beta-1-receptors in the heart will
contraction. So we can alter heart rate and strength of contraction by sympathetic activity. Strength of contraction
be changed by parasympathetic activity
Controlling Stroke Volume:
Stroke volume can be increased by: increased
activity and plasma adrenaline
Intrinsic control of stroke volume: venous return which sets the end-diastolic volume (stretch) which increases the force of contraction We can get more blood back to the heart (increase venous return) if we increase respiratory movements - decreasing intrathoracic pressure helps the filling of the heart
We can get rapid changes in respiratory movement, plasma adrenaline and sympathetic activity in the response known as
Providing Feedback - Baroreceptors:
Baroreceptors are in the aortic arch and in the
Baroreceptors in the carotid bodies feedback to the vasomotor centre via the glossopharyngeal nerve
The aortic arch baroreceptors feedback to the vasomotor centre via the
Baroreceptor Activity:
Carotid sinus baroreceptors respond to pressure between 60 and 80 mmHg Baroreceptor reflex is most sensitive around
Reciprocal Innervation:
When the receptor sees an increase in pressure it fires more - the nerve activity is increased which fires directly to the synapse and mediates an increase in parasympathetic nerve activity
Increase in baroreceptor firing = Increase in
activity
The sympathetic nerves are connected via a series of inhibitory interneurones which slows down the tonic activity
Increase in baroreceptor firing = Decrease in
Parasympathetic stimulation of the heart occurs via the vagus nerve which causes a decrease in heart rate
There is a decrease in sympathetic stimulation to the heart which causes decreased heart rate and stroke volume
Decreased sympathetic stimulation to the blood vessels causes
Reflexes controlled by carotid sinus nerve activity:
Nerve activity from the baroreceptors reflects a rise or fall in pressure
Increased Blood Pressure = huge increase in firing activity throughout from the baroreceptor
The increase in baroreceptor firing is fed back to the
which triggers increased traffic in the vagus nerve
parasympathetic activity reflects exactly what happens in terms of baroreceptor activity
Increase in parasympathetic activity causes an increase in
production in the SAN which decreases the gradient of the pacemaker potential and causes a decrease in heart rate
Increase in baroreceptor activity also decreases the sympathetic nerve traffic which also brings about a decrease in heart rate
Sympathetic cardiac nerves also have an effect on the force of contraction - so less innervation from sympathetic nerves leads to a decrease in the force of contraction
Decrease in sympathetic activity also leads to an increase in vessel
Microcirculation: the circulation for every individual tissue/organ in the body
Consists of: o 1st order arterioles o Terminal arterioles o Capillary o Pericytic (post-capillary) venule o Venule
Surrounded by large amounts of
Blood Flow:
The overall aim of the cardiovascular system is to achieve adequate blood flow through the capillaries
Blood flow rate: volume of blood passing through a vessel per unit time
F = ΔP / R where ΔP =
and R=
The pressure at the beginning of arterioles vs. Pressure at the beginning of capillaries determines blood flow rate through tissues
R = vascular resistance -Hindrance to blood flow due to
between moving fluid and stationary vascular walls
Influencing factors: Blood viscosity – is relatively constant though Vessel length – increased length, increased resistance (although length is relatively constant) Vessel radius – variable (R α 1/r4, therefore if the radius is halved, the resistance is increased 16x)
Microvessels - Arterioles:
Major resistance vessels, mean arteriole pressure (MAP) is
F organ = MAP/ R organ
Vasoconstriction/Vasodilation:
The state of
of the arterioles within that tissue also determine flow:
Vasoconstriction- decreases radius, increases vascular resistance therefore decreases flow rate
Vasodilation- increases the radius, decreases the resistance therefore increases flow rate
The radii of arterioles are adjusted independently to accomplish two functions: o Match blood flow to the metabolic needs of specific tissues – regulated by local
controls
Help regulate arterial blood pressure – regulated by
1. Matching blood flow to the metabolic needs of specific tissues (depending on the body’s momentary needs)
Chemical response: Active
Increase metabolism therefore increase glucose requirement and oxygen consumption
Physical response:
E.g. Reduced blood temperature on superficial structures, e.g. the skin
Sensed locally, then in order to decrease blood flow to tissue
vasoconstriction occurs to divert blood from the tissue
E.g. 2. Physical stretch
response to physical stretch of arterioles
2. Help regulate arterial blood pressure
Apply F= ΔP / R to the entire circulation, F is
ΔP is
R is TPR
Neural Control:
Cardiovascular Control Center (CCC) in the Medulla (part of brain stem) sends a profound
signal. This can be used after significant blood loss, as it preserves the MAP but is not a good long term system, as it leads to dysfunction and infarction
α receptors within the periphery and β receptors within the heart respond to this neural signal o β receptors especially important as they can result in an increase in heart rate
Hormonal Control:
Vasoconstrictors: o Vasopressin – Posterior Pituitary Gland o Angiotensin II – Lungs
Hormones which act on α and β receptors to increase sympathetic activity o Adrenaline o Noradrenaline – both from adrenal glands
Microvessels – Capillaries:
Capillary exchange – delivery of metabolic substrate to the cells of the organism
Design is specific – accentuates function: Cell wall is
Diameter of lumen (7 micrometers), Extensive branching increases
Therefore capillaries are ideally suited to enhance diffusion (via FICK’S LAW): o Minimise diffusion distance o Maximum diffusion time o Maximise surface area
Capillary Network depends on: Highly metabolically active tissues – denser capillary networks
Structure: Continuous-
Most common – continuous flattened endothelial cells with
-filled gap junctions
As blood flows through the capillary: o Nutrients diffuse across junctions o LIPO molecules diffuse across cells o Transport proteins present to transport larger molecules into tissues
Fenestrated-
Circular fenestrae- circular holes about
nm large allow slightly larger molecules to leave the blood and enter the tissues
E.g in the
Discontinuous-
Very large gap junctions, therefore large molecules i.e. White blood cells can leave blood and enter tissues (and vice versa) e.g.
When a volume of protein free plasma filters out of the capillary, mixes with the surrounding interstitial fluid (IF) and is reabsorbed-
Two important forces affect the bulk flow: the
forces-
pressure– derived from the heart, and drives fluid into surrounding tissues
pressure-derived from the fact there is an increased concentration of plasma proteins in the blood, but not in the surrounding IF. This generates an osmotic force pulling water back into the capillaries
Starling’s Hypothesis: there must be a balance between the hydrostatic pressure of the blood in the capillaries and the osmotic attraction of the blood for the surrounding fluids.
and whereas capillary pressure determines transudation, the osmotic pressure of the proteins of the serum determines
The oncotic pressure along the capillary remains relatively constant, but there are changes in the hydrostatic pressure:
The hydrostatic pressure at the venous end of the capillary is
than the arterial end
When the pressure inside the capillary > in the IF, there is a net loss of fluid into the surrounding tissues (Hydrostatic pressure > Oncotic pressure) – This is known as
When the oncotic pressure > hydrostatic pressure, there is a net reabsorption of fluid back into the capillary. This occurs at the venous end. This is known as
There is a net loss of fluid from the capillaries, as the oncotic pressure is never great enough to reabsorb all the fluid lost by ultrafiltration
Therefore a mechanism is required for the return of this loss of fluid to the capillaries – this is the role of the
system
The Lymphatic System:
Initial Lymphatics- Lymphatic
are interwoven with capillaries
These are blind-ended, therefore do not form complete loop therefore fluid which enters cannot leave
The excess fluid in the capillaries is then drained back into the blood. All excess fluid is eventually drained into the blood by the lymphatic system
Lymph Nodes:
Important for immune
Filled with immune cells; excess fluid passes through the lymph nodes before draining into the blood
The organ which acts as a giant lymph node is the
Lymph Flow:
No heart – relies on skeletal muscle contraction etc
Areas where lymphatic system returns fluid, i.e. drainage ducts: o Right lymphatic duct o Thoracic duct o Right & left subclavian veins
If the rate of production of fluid > rate of return, this leads to
Parasitic blockage of lymph nodes may also lead to Oedema, e.g.
the biochemical process that enables both the specific and regulated cessation of bleeding in response to vascular insult
Role–
Prevent
Enable tissue
modulate inflammation
Important clinical applications –
Diagnosis of bleeding disorders o Treatment of bleeding disorders o Identification of risks for thrombotic disease o Treatment of thrombotic disease o Monitoring of anticoagulant drugs
Haemostatic plug formation:
The response to injury to
cell lining. Consists of 4 stages:
Vessel
Primary haemostasis – formation of an unstable
plug
Secondary haemostasis – stabilisation of the plug with
Vessel repair and dissolution of clot
Vessel Constriction:
Vascular smooth muscle cells contract locally, limiting blood flow to the injured vessels
This is a local contractile response to injury, and is mainly important in small blood vessels
A normal vessel wall consists of:
A layer of endothelial cells –
barrier, which again consists of anticoagulant proteins:
GAGs – glycosaminoglycan TFPI - tissue factor pathway inhibitor TM - thrombomodulin EPCR - endothelial protein C receptor
Subendothelium which is
and consists of: Elastin Collagen VSMC (tissue factor) – vascular smooth muscle cells Fibroblasts (tissue factor)
Other vital components of haemostasis circulate in the blood, in a quiescent state: o Platelets o Clotting factors o Plasma proteins
Within a few seconds of injury, these components endeavour to minimise blood loss via
Primary haemostasis – formation of an unstable platelet plug
Platelets -
Circulate in the blood and are derived from
in the bone marrow
Have a granulated cytoplasm, and are highly specialised
plasma cells
Many different ultrastructural features
Formation of the plug consists of: Platelet
-recruitment of platelets from flowing blood to site of injury
Platelet
– formation of the plug
Adhesion:
Within the blood, there are circulating platelets and VWF-
These do not interact, as the VWF are in a
conformation therefore their binding sites are hidden from the platelets – binding sites are called Gp1b
Vascular injury damages the endothelium and exposes the sub-endothelial matrix which consists of
The sub-endothelial collagen then binds to VWF, recruiting them to the endothelial surface The rheological (flowing force) shear forces of flowing blood through the vessel then unravels the VWF on the endothelial surface
Unravelled VWF has exposed binding site (Gp1b) therefore the
bind. The platelets can also bind directly to the exposed collaged via Gp1a, but this is only under
shear forces.
Activation
-Conversion from a passive to an interactive functional cell
Change shape (spreads and flattens), change membrane composition
Present new
on their surface
The platelets bound to the collagen or VWF release ADP and thromboxane – these activate the platelets
Aggregation- Activated platelets bind more tightly to the collagen and
via GpIIb/IIIa which also binds
which develops the platelet plug
The platelet plug helps slow bleeding and provides a surface for coagulation
Secondary haemostasis – stabilisation of the plug with fibrin
Also known as blood
Stops blood loss
Complex biochemical process
Components involved from: o Liver – most plasma
proteins
o Endothelial cells – VWF. TM, TFPI o Megakaryocytes – VWF, FV
These clotting factors circulate as inactive precursors -
then activated by specific proteolysis (to form either as serine protease zymogens or cofactors)
Look at notes on this and tissue factor pathway
Consists of two pathways; intrinsic and extrinsic:
Intrinsic pathway – initiated when
is activated (not biologically as important)
FVIIIa is the only
all other activated clotting factors are serine proteases
Extrinsic pathway – primary driver of clotting cascade. Steps include:
1) Initiated when TF on surface of cells (which normally do not come into contact with blood) are exposed to plasma clotting factors
TF + FVIITF-FVIIa complex , 2) TF-FVIIa then activates FIX and
FXa activates
inefficiently leading to the generation of trace amounts of thrombin
Thrombin can then activate FVIII and
which function as non-enzymatic cofactors for FIXa and FXa, respectively.
FIXa-FVIIIa catalyses the conversion of increased quantities of
FXa-FVa catalyse enhanced generation of thrombin (more efficient by bypassing initial step)
Thrombin at the site of vessel damage converts fibrinogen (Fbg) to
which is the molecular scaffold of a clot.
Inhibitory coagulation mechanisms help keep clotting to the site of vessel injury, therefore deficiencies in these mechanisms are
TFPI (Tissue Factor Pathway Inhibitor)-
Targets initial tissue factor of
pathway, as well as FXa
This leads to the formation of a TF/FVIIa/Xa/TFPI complex
This shuts down the coagulation pathway
The Protein C anticoagulant pathway (Activated Protein C/APC & Protein S)
APC --> Protein
which targets FVIIIa and FVa
Generated thrombin then binds to
of endothelial cells, which shuts down any further thrombin generation
Antithrombin:
SERPIN (serine protease inhibitor)
Inhibits FIXa, FXa and
Fibrinolysis:
Restores vessel integrity because
binds to the fibrin clot, and via TPA (tissue plasminogen activator) is converted to plasmin
Plasmin then cleaves and degrades the fibrin clot into soluble fragments known as FDP (fibrin degradation products), which are then cleared by the
FDP is elevated in DIC (disseminated intravascular coagulation)
tPA and a bacterial activator-
are used in therapeutic thrombolysis for Myocardial Infarction, ischaemic stroke etc. these are known as
Abnormal Bleeding – the result of a(n)
in fibrinolytic factors and anticoagulant proteins, and a(n)
in coagulation factors and platelets
Characteristics:
• Spontaneous • Out of proportion to the trauma/injury • Unduly prolonged • Restarts after appearing to stop
Examples:
Epistaxis not stopped by 10 mins
or requiring medical attention/transfusion.
Cutaneous haemorrhage or bruising without apparent trauma (esp. multiple/large).
Prolonged (>15 mins) bleeding from trivial wounds, or in oral cavity or recurring spontaneously in 7 days after wound. Spontaneous GI bleeding leading to
Menorrhagia requiring treatment or leading to anaemia, not due to structural lesions of the uterus.
Heavy, prolonged or recurrent bleeding after surgery or dental extractions.
Defects of Primary Haemostasis (the formation of an unstable platelet plug):
Patterns of bleeding-
Easy
Nosebleeds, Gum bleeding, Menorrhagia, bleeding after
Petechiae (specific for thrombocytopenia)
o Typical of thrombocytopenia (decreased platelets) –
Defects of secondary haemostasis (fibrin mesh formation/coagulation):
Definition: Deficiency or defect of coagulation factors I-
Common examples include:
Haemophilia: FVIII or
(hereditary due to genetic defect)
Liver disease (acquired – most coagulation factors are made in the liver)
Drugs-
-inhibits formation
Dilution
Consumption (DIC – disseminated intravascular coagulation) (acquired)
Acquired coagulation disorders – DIC:
Generalised activation of coagulation –
Haemostasis then takes place
blood vessels, and throughout the general circulation
Associated with sepsis, major tissue damage, inflammation
Consumes and depletes coagulation factors &
Activation of fibrinolysis depletes
Consequences: o Widespread bleeding - from iv lines, bruising, internal o Organ failure – due to deposition of fibrin in vessels
Patterns of bleeding:
Often delayed (after primary haemostasis)
Deeper: joints and
Not from small cuts
Nosebleeds are
Bleeding after trauma/surgery
Easy bruising which is known as
Spontaneous bleeding into joints is known as
-Hallmark of haemophilia, increases pressure in joints and very painful and damaging
Defects of clot stability – excess fibrinolysis:
Can be used in therapy to break down clots after MI (but this must be done carefully as can lead to haemorrhage)
Due to either: o Excess
components – plasma, tPA Can occur with some tumours
Deficient
components – antiplasmin Can have a genetic antiplasmin deficiency
Thrombosis – result of a(n)
in fibrinolytic factors and anticoagulant proteins, with a(n)
What is thrombosis?
Intravascular
Effects of thrombosis:
Obstructed flow of blood
Embolism
Venous Thrombo-embolism:
Deep Vein Thrombosis (DVT) – venous return of blood is obstructed
Causes painful, swollen
Pulmonary embolism – causes shortness of breath, chest pain, may lead to sudden death
Prevalence- 1 in
per annum (with incidence doubling each decade)
However is cause of 10% of hospital deaths, and is a preventable cause of death
Consequences:
Death- VT mortality is
Recurrence - 20% in first 2 years and 4%pa thereafter
Severe TPS in 23% at 2 years is known as
syndrome
Why do some people get thrombosis? • Genetic constitution • Effect of age and previous events, illnesses, medication • Acute stimulus
The 3 contibutory factors to thrombosis is known as
and they are blood, vessel wall and
Blood- dominant in
thrombosis
Deficiency of anticoagulant proteins – antithrombin, protein C, protein S
Increased coagulant proteins & activity – Factor VIII , Factor II &others
Factor V Leiden (increased activity due to activated protein C resistance) and thrombocytosis which is increased
vessel wall - dominant in
Many proteins active in coagulation are expressed on the surface of endothelial cells and their expression altered in inflammation Thrombomodulin Tissue factor Tissue factor pathway inhibitor
Flow - complex, contributes to both
Reduced flow which is known as
increases the risk of venous thrombosis. This can occur due to:
surgery, fracture, long haul flight and bed rest
- increased risk of thrombosis
Clinical: o Thrombosis at young age o ‘idiopathic thrombosis’ o Multiple thromboses o Thrombosis whilst anticoagulated
Laboratory: o Identifiable cause of increased risk AT deficiency Factor V Leiden global measures of coagulation activity.
Acquired risks for thrombosis:
Numerous conditions will alter blood coagulation, vessel wall and/or flow to precipitate thrombosis or make it more likely: The
pregnancy, malignancy, surgery and inflammatory response
Therapy and venous thrombosis:
Treatment- clot
Limit recurrence/extension- Increase anticoagulant activity - e.g:
Lower Procoagulant factors – e.g.
Prevention (NICE Guidelines 2010):
Assess individual risk and circumstantial risk, All patients admitted should have VTE risk assessment o Give prophylactic antithrombotic therapy o E.g. heparin for in-patients o TED stockings
Design of the Circulation
The cardiovascular system consists of two pumps and circuits (systemic and pulmonary) that are connected in series . Both circulations are very similar - there are elastic arteries, resistance vessels and exchange manoeuvres
Structure of the Systemic Circulation:
Initially when blood leaves the heart it is carried by large, thick-walled, elastic arteries which act as dampening vessels
Then you move into smaller arteries and arterioles which have extensive
muscle in their walls which regulates their diameter and produces a resistance to blood flow
A lot of the pressure drop in the arteries takes place in the small arteries and arterioles
The veins are very stretchy and highly compliant so they act as a
for blood volume
In terms of cross-sectional area, the
make up the largest cross-sectional area in the CVS - this is because it has an exchange function
Much of the blood at any one point rests in the veins and venules - this is why they are considered a reservoir for blood volume
You can load up the vessels with blood under normal (rest) conditions, but if you need to exercise you get
meaning that you decrease the amount of stored blood and move more blood back to the heart
By shifting the blood from the reservoir to the heart you produce more venous return and more cardiac output
The Fluid Circuit is similar to an Electric Circuit: Electrical circuit V=IR Fluid circuit- P=QR (Darcy's law) where P is
Q is
R is resistance
Pressure Difference can be estimated as being mean arterial blood pressure
Physiologically, the regulation of flow is achieved by variation in
while blood pressure remains relatively constant (relies on mechanisms to detect blood pressure and feedback to keep it constant)
We can direct the blood by specific contraction and relaxation of the blood vessels that serve the particular vascular bed that we're interested in
Pressure throughout the circulation :
Pressure falls across the circuit due to
pressure losses
Small arteries and arterioles present
resistance to flow
On the right side, the pulmonary artery presents a resistance to flow as well
The resistance to blood flow depends on THREE variables:
Fluid
- not fixed but in most physiological conditions this remains more or less constant
Length of Tube - fixed - the lengths of the blood vessels remains constant
Inner Radius of Tube - variable
The main determinant of resistance is
Distribution of Blood Flow to Organs:
When exercising, we can boost our cardiac output up to
L/min. By changing the radius of various vessels we can increase the blood flow to the working skeletal muscle - by constricting some vessels and dilating others to direct the blood to the place that needs it most
What sort of flow occurs in vessels?
It is known as
flow.
Blood generally flows in stream lines which don't tend to interfere with one another - it is laminated flow and hence laminar flow. It
be heard. When you measure blood pressure, you pump the cuff up to obstruct blood flow and when you start to release the cuff slowly, the blood will start pushing through the cuff producing
flow which you can hear -sounds of
When you partially occlude the vessel and blood starts to flow through in a turbulent manner, you hear a soft tapping sound
When you further drop the pressure in the blood pressure cuff, you won't hear anything at all because the vessel is no longer occluded and the blood starts to flow in a laminar fashion which you can’t hear
Turbulence is characterised by whirlpool like regions and the velocity of the fluid
constant in turbulent flow whereas it is constant in laminar flow
You need to be able to differentiate between laminar and turbulent flow because turbulent flow could bring about pathophysiological changes
Flow, Viscosity and Shear:
Blood flows quickest in the
This is because there are adhesive forces which attach the blood to the vessel walls
The velocity gradient that is established - the difference between the highest velocity blood in the middle of the lumen and the lowest velocity blood that adheres to the blood vessel walls - The
When shear rate is multiplied by viscosity you get
This disturbs endothelial function which is important for laminar flow and the production of various transmitter substances which give rise to vessel dilation and constriction
When shear stress is
it promotes endothelial cell survival so the endothelial cells line up and produce substances normally
If you have low, disturbed or changed shear stress (turbulent flow), endothelial
is stimulated which has a bearing on vasoconstriction, coagulation, platelet aggregation and atheroma formation
More on Shear Stress and Endothelial Function:
Shear stress is important because it determines how happy the endothelial cells are and determines their function
Measuring Blood Pressure:
You measure the changes in
You put a cuff around the upper arm and you increase the pressure until the cuff pressure exceeds arterial pressure
You place the stethoscope distal to the cuff - initially you won't hear anything because the blood flow is occluded
As you let the cuff down, you eventually get to a point where the pressure in the cuff is just overcome by the pressure in the artery
At this point, blood starts to squirt through the occlusion and sets up
flow - you hear a light tapping sound
If you continue to reduce the pressure in the cuff, you reach a point where you have no occlusion in the artery and so blood will start to flow in a laminar fashion again which you can not hear - this is the
blood pressure
Summary: Sounds APPEARS = Systolic Blood Pressure Sound DISAPPEARS = Diastolic Blood Pressure
The difference between systolic and diastolic blood pressure =
Mean Blood Pressure = Diastolic + 1/3 of pulse pressure
Why do ventricular and aortic pressure differ?
Once the aortic valve closes, ventricular pressure falls
but aortic pressure falls
This is explained by the
of the aorta which buffers changes in pressure and so it doesn't drop to zero like the ventricular pressure - the pressure is maintained by the elasticity of the vessel
Dichrotic Notch - when blood enters the aorta faster than it leaves the aorta, about 40% of the stroke volume is stored by the elastic arteries
When the aortic valve closes, the ejection of blood stops but there is a
because the arteries and the aorta are very elastic which produces the dichrotic notch Pressure falls slowly downstream of the aorta hence showing that the elasticity allows it to act as a
This damping effect is sometimes called the
effect. If arterial compliance decreases (e.g. with age) the damping effect of the Windkessel is reduced and the pulse pressure will
The effect of pressure on the walls of vessels:
The pressure inside the vessel-
pressure- determines the distension of the vessel wall The relationship between transmural pressure and wall tension is determined by the law of
T=PxR
Circumferential stress also depends on vessel wall thickness
The relationship between the transmural pressure and vessel volume is called the
Compliance is dependent on vessel elasticity
Aneurysm:
Over a prolonged period, the vessel walls can weaken causing a balloon like distension. Aneurysms form as a result of Laplace's law
If an aneurysm forms in the blood vessel, this means that for the same internal pressure, the inward force exerted by the muscular wall must also increase
However, if the muscle fibre is weakened and the compliance isn't great, the force needed to withstand the internal pressure cannot be produced and so the aneurysm will continue to expand
Summary of Laplace's Law: The larger the vessel radius, the greater the wall tension required to withstand a given internal fluid pressure
Compliance Properties of Arteries and Veins:
Relatively small changes in venous pressure distends veins and increases the volume of blood stored in them
For the same pressure, veins can hold a
volume of blood
Venous compliance is about 10 to 20 times greater than arterial compliance
When you change the nervous supply to the smooth muscle causing contraction, you decrease the venous volume and increase venous pressure
When you stand up quickly, gravity makes the blood pool in the legs which is due to the venous
When it pools in the legs, this reduces venous return to the heart which means that cardiac output
and you get less blood going to the brain
A mechanism to compensate for the postural hypotension is that you get venous
which means that more blood is returned to the heart and cardiac output is increased
Gravity and Blood Pressure across the Circulation:
At any particular location, the gradient of pressure from large artery to capillary is
so flow always occurs the normal way. The major effect of gravity is on the distensible veins in the
Why we don't faint when we're standing:
Standing causes activation of the
nervous system which stiffens and constricts veins
The arteries are constricted to increase total peripheral resistance and maintain blood pressure
Also, when you stand up there may be a slight increase in heart rate and an increase in the force of contraction which allows more blood to return to the brain
Failure of these mechanisms can lead to fainting known as
The failure of the mechanisms could lead to
Muscle and Respiratory Pumps:
Skeletal Pump - the contraction of the muscle squeezes blood back through the veins to the heart This assists the movement of blood back to the heart and
venous capacitance
Respiratory Pump - as we breathe in, we expand our chest and our intrathoracic pressure decreases which allows blood to come back to the right atrium and increase venous return These two simple mechanisms allow us to be able to stand up for long periods of time without fainting
Problems with Standing:
If you have incompetent valves, this could lead to
veins
The autonomic nervous system: Consists of the parasympathetic and sympathetic nervous systems
Sympathetic nervous system is organised around the thoracic and
spinal cord
Cardiovascular control:
Baroreceptors in carotid sinus and aortic arch sensitive to
Increased frequency of impulsesreduced inhibition of sympathetic activity from solitary tract nucleus increased blood pressure through increased vasoconstriction
α1 receptors at end of pre-ganglionic neurone, α2 receptors in
β2 receptors in heart via vagus nerve
Effector nerves: Sympathetic outflow-
Paravertebral sympthatic chain ganglion – neurotransmitter is acetylcholine therefore is a
receptor
Post-ganglionic fibre contains lots of
vesicles which are released on depolarisation, binding to the adrenergic receptor on the effect organ.
The NA is then either taken up by the neurone and repackages, or taken up by the effector organ and broken down by
Parasympathetic outflow-
Parasympathetic ganglia are in or near effector organ, and involve
Effector organ also has cholinergic receptor, which binds to the acetylcholine released by the postganglionic neurone. This acetylcholine is then recycled
Catecholamines: Noradrenaline and adrenaline are synthesised in the terminal
They are then removed from the neuroeffector junctional synapse via uptake systems:
Neuronal reuptake and recycling, or degradation into deaminated metabolites by MAO. Extraneuronal uptake into effector organ and degradation by COMT or MAO
Adrenoceptors:
Two groups of effects: Excitatory effects on smooth muscle (constriction). Mediated by
-adrenoceptors
lead to an increase in intracellular
Relaxant effects on smooth muscle, stimulatory effects on heart
-adrenoceptor mediated
lead to an increase in cyclic AMP, which causes an increase in Ca2+ in the heart but a decrease in smooth muscle
β- receptors:
β1 adrenoceptors located on: Cardiac muscle and smooth muscle of the
β2 adrenoceptors located on: bronchial, vascular and uterine smooth muscle
β3 adrenoceptors located on: smooth muscle of GI tract and
α- receptors: α1-adrenoceptors: located post-synaptically i.e. predominantly on effector cells
important in mediating constriction of resistance vessels
α2 -adrenoceptors: located on
nerve terminal membrane
their activation by released transmitter causes negative feedback inhibition of further transmitter release. Some are post-synaptic on vascular smooth muscle
Receptor coupling:
α1-adrenoceptors- coupled with G-protein linked receptor which activates the phosphlipase C pathway, which leads to an increase in free Ca2+ and activated protein kinases (involving IP3 and DAG)
α2-adrenoceptors- coupled with
activates adenyl cyclase, which converts ATPcyclic AMP leading to a decrease in intracellular
Effects of catecholamines on activation of adrenoceptors:
Natural - Noradrenaline – α1, α2, β1 - Adrenaline – α1, α2, β1, β2 - Dopamine – weak effects at α1, β1, but has own receptors
Synthetic - Isoprenaline - β1, β2 (unselective beta-agonist) - Phenylephrin - α1 (selective alpha-agonist)
Response of major vascular beds:
Skin (alpha receptors): Noradrenaline – constriction, Adrenaline –
Isoprenaline – no effect
Visceral (alpha receptors) o Noradrenaline –
Adrenaline – constriction Isoprenaline – no effect (slight dilation)
Renal (alpha & beta receptors) – constriction, Noradrenaline – constriction, Adrenaline – constriction and Isoprenaline-
Coronary (alpha & beta1 receptors) – dilation
Noradrenaline –
Adrenaline – dilation and Isoprenaline – dilation
Skeletal muscle (alpha & beta2 receptors): Noradrenaline – constriction, Adrenaline – dilation and Isoprenaline –
The Renin-Angiotensin System:
Renin, an enzyme, is secreted by
cells of renal afferent arteriole which converts angiotensinogen to
which is then converted to angiotensin II by
this then enters the zona glomerulosa of the
to form
Stimuli for renin release:
A decrease in the renal perfusion
a decrease of blood pressure in the pre-glomerular vessels, A decrease in arterial blood pressure.
Haemorrhage, salt and water loss, hypotension (low blood pressure). A change in Na+ or
concentration. β1-receptor activation in the kidney (sympathetic nervous system).
NaCl reabsorption at the macula densa -which are a group of cells in the
Pharmacologic manipulation of renin release
Loop diuretics – block NaCl reabsorption at macula densa
NSAIDs – block renin release via inhibition of COX
ACE inhibitors – block the synthesis of
AT1 blockers (Ang II receptor antagonists) – block vasoconstriction and aldosterone synthesis and secretion
Alpha2 and beta1 blockers - block receptor activation in the kidney, inhibiting renin release
AT1/Ang II type I receptors: Are coupled with a
It also couples to phospholipase A2
The AT1 receptors are located in the blood vessels, brain, adrenal glands, the kidneys and the heart. Activation of the AT1 receptors works to
blood pressure, and stimulate aldosterone secretion
Effects of angiotensin II:
Peripheral resistance- Direct
-There is enhanced action of peripheral
due to increased release and reduced uptake
-increased sympathetic discharge
-release of catecholamines from the adrenal glands.
Renal Function:
-Direct effects to increase
reabsorption in the proximal tubule.
-Synthesis and release of aldosterone from the adrenal cortex.
Altered renal haemodynamics. Renal vasoconstriction. Enhanced noradrenaline effects on the kidney.
Cardiovascular structure:
Haemodynamic effects: - Increased preload and afterload. - Increased vascular wall tension.
Non-haemodynamic effects: -Increased expression of
Increased production of growth factors. Increased synthesis of extracellular matrix proteins.
Pharmacology of ACE Inhibition:
ACE is needed to convert
to
which increases blood pressure (by vasoconstriction and stimulation of the SNS).
Therefore inhibition of ACE will prevent angiotensin II production, and so ACE inhibition reduces blood pressure.
At the same time, a local hormone called
is also broken down by ACE.
It is an important local vasodilating hormone.
ACE inhibition therefore stops the bradykinin from being broken down, and so the bradykinin therefore will have vasodilating effects, and so here ACE inhibition further acts to reduce the blood pressure
AT2 ./ Ang II type 2 receptor antagonist actions:
No effects on the bradykinin system.
Selectively blocks the effects of Angiotensin II. o Pressor effects. o Stimulation of the noradrenaline system. o Secretion of aldosterone. o Effects on renal vasculature. o Growth-promoting effects on the cardiac and vascular tissue
Uricosuric effect-increased amount of
in the urine
Aldosterone:
Physiological effects – maintains body content of Na+, water and
Increases Na+ (and hence water) retention
Increases K+ (and H+) excretion
Pathophysiologic effects in CVD:
Myocardial fibrosis and
Inflammation, vascular fibrosis and injury
Prothrombotic effects – impaired
Central hypertensive effects
Endothelial dysfunction, Autonomic dysfunction
Effects of stress:
Increased blood pressure and heart rate
Increased Na+/water
Increased coagulation
Decreased fibrinolysis
Cardiac Position and Borders: The long axis of the heart is at an angle to the long axis (midline) of the body, with the apex (formed by the
part of the left ventricle- the bottom part furthest away from the midline of the body) in the left side of the body (Approx 2/3rds of the heart lies in the left side of the body)
The heart lies between the
and the spine. The sternum is
to the right ventricle. The spine is
to the left atrium
Functionally consists of two pumps separated by a partition. Each pump consists of an atrium, ventricle separated by a valve.
The right pump receives
blood and sends it to the
and the left pump receives
The heart can be thought of as having 5 surfaces: Posterior, anterior, left pulmonary, right pulmonary and
The posterior consists of left atrium, small part of
and the
(beginning) parts of the great veins:
Superior vena cava (enters top right atrium- delivering blood from body). Also known as superior caval vein
Inferior vena cava (enters bottom
- delivering blood from body). Also known as inferior caval vein.
Coronary sinus (enters
medial to the inferior vena cava opening delivering deoxygenated blood draining from the coronary veins, i.e. from the heart itself)
Pulmonary veins (enter either side of
- delivering blood from lungs)
There are four pulmonary veins: right upper, right lower, left upper and left lower
The anterior surface consists of:
Mainly the
some of the right atrium and left ventricle
The pulmonary
emerges from the right ventricle, and divided into the left and right pulmonary artery
It has a central position and a spiral relationship with the
which emerges from the left atrium
Cardiac Chambers:
The four chambers of the heart are separated by interatrial, interventricular and atrioventricular septa:
Atrial Chambers-
Right Atrium- Venous Sinus: superior vena cava, inferior vena cava and coronary sinus. The inferior vena cava is guarded by the
and the coronary sinus is also guarded by a valve
The right atrium can be divided into two continuous spaces, divided by the
Characteristic
muscle bundles cover the walls of the atrium on the triangular appendage in the space anterior to the crest, known as the
In the space posterior to the crest has smooth, thin walls and both venae cavae and the coronary sinus empty into this space
Interatrial septum:
The right and left
are separated by the interatrial septum
A depression/infolding rim in the septum (just above the
of the inferior vena cava in the right atrium) is clear – this is the
The oval fossa effectively is a flat valve, which prevents blood flow directly between the atrial chambers
The oval fossa marks a location important for
circulation as it allows oxygenated blood to bypass the non-functioning lungs and enter the right atrium passing directly to the left atrium
when the lungs begin to function, this hole in the septum is supposed to close
Left Atrium:
Posterior half is smooth and receives blood from the four
Anterior half is contiuous with the
and contains pectinate muscles. However in the left atrium, there is no distinct separation (like the terminal crest) between these two halves
The crescent shape of the oval fossa is apparent in the anterior wall of left atrium, and is known as the valve of
(which prevents blood flow from left to right atrium)
However this valve may not completely fuse with the oval fossa in adults, which may leave a passage between the two atrial chambers, leaving a
foramen ovale (effectively a hole in the septum, leading to shunting of blood between the atria)
Ventricular Chambers:
Both ventricular chambers have an inlet, apical and
components, and constant apical
Right Ventricle:
Forms most of the anterior surface of the heart, and a portion of the diaphragmatic surface
Inlet component – the tricuspid valve and the
Apical component – trabecular portion
Outlet component -
It is to the right of the right atrium, and in front of and left of the right atrioventricular orifice. Blood therefore enters the ventricle moving in a horizontal and forward direction
Outflow portion: pulmonary
– leads to the pulmonary trunk – has smooth walls
Inflow portion wall has substantial complex muscle structures called
; these are either attached continuously to the walls forming ridges, or attached at both ends forming bridges
Trabeculations which are only attached at one end to the ventricular surface and the other end are attached to
(fibrous tendon-like chords which connect to the free edges of the tricuspid valve), are also known as
muscles. There are 3 types of papillary muscles in the right ventricle depending on their point of origin
Anterior- arises from the anterior wall and is the
Posterior- arise from the posterior wall
Septal- most inconsistent as either small or absent, but allow chorea tendineae to emerge directly from the interventricular septum
The septomarginal trabecula/ moderator band: single trabecula which forms a bridge between the lower portion of the intraventricular
and the base of the anterior papillary muscle, carrying the right atrioventricular bundle to the anterior wall of the right ventricle during cardiac conduction
Any of the individual muscle structures within the right ventricle have the potential to become atrophied, or necrose following a myocardial infarction
Intraventricular Septum:
The left ventricle is some-what
to the right ventricle, so the interventricular septum forms some of the posterior wall of the right ventricle (and is to the left).
The septum is described as having two parts: muscular and
The muscular part is thick and forms the major part. The membranous part is thin and forms the
part of the septum.
A third part of the septum may be considered to be atrioventricular as its superior location places it between the left ventricle and the right atrium
Left Ventricle:
Contributes to the anterior, diaphragmatic and left pulmonary surfaces of the heart. Forms the
of the heart.
Blood enters from the left atrium through the
orifice; flows in a left forward direction to the apex
Chamber is conical, longer than the right ventricle and has a thicker layer of
Inlet – holds the atrioventricular valve
Outflow tract is posterior to the infidibulum of the right ventricle and leads to the
Apical component: Trabeculations are fine/delicate in comparison with right ventricle
Papillary muscles are larger than those of the right ventricle, and consist of only anterior and posterior muscle
Preload: the stretch or filling of the ventricles
they contract
Afterload: the load/pressure against which the ventricles eject blood after
of the aortic/pulmonary valve
ventricular heart beat is divided into two main phases: Diastole: ventricular
during which the ventricles fill with blood. Split into 4 sub-phases
Systole: ventricular contraction when blood is pumped into the
Split into 2 sub-phases
Cardiac cycle: a description of mechanical and electrical events, volume changes and sounds associated with the heart beat. It consists of:
Atrial systole (resulting in the end diastolic volume), Isovolumetric ventricular contraction, Ventricular ejection, Isovolumetric ventricular relaxation and Late diastole
ATRIAL SYSTOLE
Mechanical events:
Just prior to atrial systole, blood flows passively through the open
Atrial depolarisation leads to contraction of
which “tops off” the volume of blood in the ventricles
Changes in pressure & volume:
As atria contract, the “a wave” forms due to the increase in atrial
Blood is also pushed back into jugular vein, causing a wave in jugular venous pulse
Electrocardiogram: SAN activation leads to
of atria
Heart sounds
sound should be heard, but 4th heart sound may be heard as an abnormality – occurs in congestive heart failure, pulmonary embolism or tricuspid incompetence
ISOVOLUMETRIC CONTRACTION
Occurs just as the
depolarise- is the interval between AV valve closure and semi-lunar valve (aortic and pulmonary) opening
Changes in pressure and volume:
The AV valves
as the ventricular pressure exceeds the atrial pressure. Since the AV and semi-lunar valves are closed, there is
movement of blood out of the ventricles, just an increase in pressure approaching the aortic pressure
Echocardiogram: Ventricular depolarisation
Heart sounds: Consider the heart sound to be LUB- DUB Ventricular depolarisation is the 1st heart sound (lub) – this is due to the closure of the AV valve with associated vibrations
RAPID EJECTION:
Ventricular muscle walls undergo
contraction, pushing blood out of the ventricles. Semi-lunar valves open
as the ventricles contract, the pressure within them exceeds the pressure in the
and pulmonary arteries. When the semi-lunar valves
the volume of the ventricles decreases
the right ventricular contraction pushes the tricuspid valve slightly into the atrium, creating a small wave into the jugular vein – “c wave” observed in yellow graph
Electrocardiogram: No changes
Heart sounds: No sounds
REDUCED EJECTION:
Mechanical events: Marks the end of ventricular
Aortic and pulmonary valves begin to
Pressure and volume changes:
As the blood flow from the ventricles
the ventricular volume decreases more slowly as the pressure in the ventricles fall blow that in the arteries, blood begins to flow back causing the
valves to close
Electrocardiogram: Ventricular
Heart sounds: No heart sounds
ISOVOLUMETRIC RELAXATION:
Beginning of
Aortic and pulmonary valves
AV valves remain shut and atria fill with blood
atrial pressure rises as volume of blood in atria
Blood pushing on the tricuspid valve gives a second jugular pulse (“v wave” on yellow graph) as the aortic valve shuts, there is a rebound pressure wave against the valve as the distended aortic wall relaxes. This recoil reduces the aortic pressure and is seen as the
notch
Electrocardiogram: No change
Heart sounds: 2nd heart sound (dub) occurs when aortic and pulmonary valves close
RAPID FILLING (late diastole)
AV valves open, and the blood flows rapidly (although passively) into the
The ventricular volume
as the atrial pressure falls
Heart sound: 3rd heart sound abnormal- can signify turbulent ventricular filling due to severe hypertension or mitral incompetence
REDUCED FILLING (late diastole)
Called
Ventricles fill more slowly and the pressure difference between atria and ventricles decreases
Ventricular volume increases more
Heart sounds: No sound
Pressure volume loops:
Typical pressure of the systemic circulation:
mmHg
Typical pressure of the pulmonary circulation:
PAWP- pulmonary artery
Taken from a branch of pulmonary artery when the back pressure has been occluded
Elevation can indicate left ventricle failure, mitral insufficiency, mitral stenosis
Look at notes for pressure volume loop and Frank-Starling relationship
Blood vessels have THREE layers:
Tunica
-External layer containing blood vessels, fibrous tissue, elastin, collagen. Helps keep the shape of the blood vessel
-Predominantly smooth muscle cells able to contract or dilate depending on the type of stimulus
-Predominantly vascular endothelium has the elastic basal lamina as well – this is the exchange surface
Structure and Function:
Vascular endothelium – single cell layer that acts as the blood-vessel interface
Vascular endothelial functions:
Vascular tone management – secretes and metabolises vasoactive substances – this can cause vasoconstriction or vasodilation
Thrombostasis – secretes
substances
Absorption + Secretion
Barrier – prevents entry of bad substances hence preventing atherosclerosis formation
Growth – mediates cell proliferation
Blood vessel can regulate its own pressure depending on how much blood is flowing past it -
There are mechanoreceptors in the endothelial cells which detects an increased blood flow which then secretes vasodilators to bring the blood flow down
Overview of the FIVE key molecules:
Vasodilators:
Nitric oxide- inhibits
PGI2 (prostacyclin) - Cardioprotective molecule and inhibits aggregation of platelets
Vasoconstrictors:
TXA2 (thromboxane) - Produced in endothelial cells but also by
ET-1 (endothelin 1) and Angiotensin II (ANG II)
Vascular Tone is controlled by the balance of the forces causing vasoconstriction and vasodilation
Nitric Oxide:
Something that stimulates NO production will bind to the G-protein coupled receptor and activate
PLC converts PIP2 to IP3 and DAG
IP3 moves to the
and stimulates
efflux
The rise in intracellular calcium concentration upregulates endothelial nitric oxide synthase
eNOS catalyses the following conversion: L-arginine + Oxygen -----> L-citrulline + NO
NO exits the endothelial cell and moves to the
cell. NO moves in to the smooth muscle and upregulates the activity of Guanylyl Cyclase which converts GTP to cGMP
cGMP upregulates Protein Kinase G which eventually leads to relaxation of smooth muscle (calcium efflux reduces tension within the myocyte and stimulates relaxation)
Provision of Acetylcholine triggers the upregulation of endothelial nitric oxide - you get steady
If the endothelium is obliterated then there is no change in vessel diameter SNP is a nitric oxide
this means that we aren't relying on the endothelial cells to produce nitric oxide and so the work done by the endothelium is bypassed
Arachidonic Acid:
A phosphlipid can be converted to arachidonic acid by Phospholipase
The arachidonic acid can then be converted to Prostaglandin H2 (PGH2) by the COX enzymes (COX = cyclooxygenase)
COX 1 is expressed in
cells. If your body has an inflammatory problem, COX2 will be upregulated so typically COX2 is associated with inflammation, and hence, disease
PGH2 is a
which can be exposed to a variety of enzymes to produce different products
PGH2 can either becomes: Prostacyclin (PGI2) By Prostacyclin Synthase Thromboxane A2 (TXA2) By Thromboxane Synthase
Thromboxane is a powerful
and it stimulates platelet aggregation
Some of the other products that PGH2 can be converted to are involved in the health of the epithelia in the GI tract
Another Pathway for Arachidonic Acid - Leukotrienes:
If arachidonic acid follows the
cascade you end up with LTA4, LTB4, LTC4 and LTD4
LTD4 causes
LTD4 is associated with asthma - Montelukast therapy can reduce bronchoconstriction helping the patient breathe more comfortably
The pathways in an endothelial cell:
You can also get arachidonic acid from DAG via
Depending on whether arachidonic acid gets exposed to lipoxygenase or cyclooxygenease (COX) you either end up following the leukotriene route or
route
Prostacyclin:
Produced inside endothelial cells
Binds to the IP receptor which is coupled with
cAMP upregulates Protein Kinase A which results in
of the vascular smooth muscle causing vasodilation
Prostacyclin is also secreted into the blood where it has properties for anti-
Thromboxane:
Can bind to the following receptors: Alpha -
Beta- Vascular smooth muscle cells
Beta Receptor = coupled with phospholipase C which converts PIP2 to IP3 which results in the
of blood vessels
When thromboxane binds to the alpha receptors on platelets it results in the activation of platelets and the production of more thromboxane which has a domino effect on other platelets and stimulates aggregation
Endothelin-1:
We start off inside the nucleus, an endothelin precursor is produced which is then cleaved by Endothelin Converting Enzyme (which is embedded in the membrane) to produce endothelin-1
Endothelin-1 is then pushed out of the endothelial cell and it can bind to alpha or beta receptors
BOTH alpha AND beta receptors ON SMOOTH MUSCLE are bound to PLC which converts PIP2 to IP3 which causes
If the endothelin-1 binds to a beta receptor on the
cell- it triggers the activation of eNOS
eNOS converts L-arginine and oxygen to L-citrulline and Nitric Oxide
The Nitric Oxide then moves into the smooth muscle cells and stimulates
Antagonists which inhibit the production of the endothelin-1 precursor: Prostacyclin Nitric Oxide ANP (atrial natriuretic peptide) Heparin HGF (hepatocyte growth factor) EGF (epidermal growth factor)
Agonists which stimulate the production of endothelin-1: Adrenaline Vasopressin Angiotensin II Interleukin-1
Angiotensin II:
Angiotensinogen is a precursor for angiotensin II which is produced in the
Renin is secreted in the kidneys in response to
Renin converts angiotensinogen to
Angiotensin Converting Enzyme (ACE) converts angiotensin I to
Angiotensin II: Stimulates ADH secretion, Increases
production, increases sodium reabsorption, all three of these cause increased
Increased sympathetic activity and arteriolar vasoconstriction, both cause increased
An increase in vascular resistance coupled with an increase in water retention leads to
in blood pressure
Angiotensin Pathways:
Angiotensin II will bind to an angiotensin receptor on vascular smooth muscle cells which leads to the activation of PLC and hence the conversion of PIP2 to IP3 resulting in
NOTE: this is because IP3 production causes an increase in the transport of calcium (massive INFLUX) which will increase the amount of cross-bridge cycling that takes place
Some AT receptors are G-protein coupled but are instead bound to SRC which can upregulate the
of vascular smooth muscle cells (this may also have some effect on contractility)
These are both mechanisms to increase
Bradykinin has the
effect to angiotensin II
So breaking down bradykinin is important to cause vasoconstriction
Bradykinin itself can stimulate
Bradykinin can bind to the bradykinin receptor-1 and activate PLC which converts PIP2 to IP3 which upregulates the production of
This then moves to the smooth muscle and causes
Therapeutic Mechanisms and Side Effects:
If we want to increase the diameter of blood vessels then you need to increase the amount of
This can be done by: Stimulating the production of nitric oxide or donating nitric oxide
SNP (sodium nitroprusside) is a nitric oxide
Stimulating the production of nitric oxide is endothelium-dependent because you're relying on the cascade taking place in the endothelium to generate the nitric oxide
On the other hand, donation of nitric oxide is endothelium-independent meaning that if you needed to increase the vessel diameter and decrease the blood pressure of someone suffering from microvascular disease (who probably has some endothelial damage) then an endothelium-independent approach is favoured.
Another way of affecting Nitric Oxide is to enhance the effects of the nitric oxide that's already there
Mechanism for Nitric Oxide Donors:
Both endogenous and exogenous NO will activate
cyclase which converts GTP to cGMP. The cGMP then activates protein kinase
which causes relaxation
Mechanism of Viagra:
cGMP is converted to GMP by
GMP is metabolically inactive with regards to this pathway. Viagra is a phosphodiesterase
Effect of Low Dose Aspirin:
Aspirin causes irreversible inhibition of the COX enzymes
Aspirin has different effects on COX1 and COX2. COX1 -
COX2 - switches its function
If you reduce the conversion of arachidonic acid to PGH2 then you reduce the amounts of prostacyclin and
When thinking of thromboxane, this effect is good but aspirin also decreases the production of prostacyclin
However, with low-dose aspirin, Prostacyclin levels will decrease slightly and then remain relatively high whereas thromboxane levels continue to
This is because thromboxane is predominantly produced in the
Platelets
have a nucleus so they can't generate more mRNA to produce new proteins to build the enzyme again
So if we continue to take low-dose aspirin, we get a decrease in
but maintenance of
Blocking Voltage-Gated Calcium Channels:
There needs to be a way to block certain calcium channels without affecting the calcium channels in the heart
It just so happens that the affinity of the channel blocker to the channel is related to the
of target cells
Smooth muscle cells have a higher membrane potential (more positive) than cardiomyocytes
ACE Inhibitors:
If we inhibit ACE then not only do we inhibit the conversion of angiotensin I to
But we also inhibit the breakdown of
This stimulates relaxation because it has a vasodilatory effect
Normal vs Dysfunctional Endothelium:
The endothelium is usually smooth and blood can flow through it easily
If the endothelium is damaged then it exposes parts of the sub-endothelial layer (usually collagen) which is sticky causing platelets to adhere to it
Platelets stick and release
which stimulates the aggrgation of platelets. A platelet
forms
Summary of Mechanisms of Drug Action :
Gq protein linked receptor (PLC, PIP2, IP3, DAG): Nitric Oxide production Thromboxane action Endothelin 1 action Angiotensin II action
Guanylate Cyclase (GTP, cGMP, Protein Kinase G): Nitric Oxide action
Adnylate Cyclase (ATP, cAMP, Protein Kinase A): Prostacyclin action
There are 6 stages involved:
1.Lesion prone location within a coronary artery- Smooth muscle within the vessel wall undergoes adaptive
2. Type II lesion - macrophage
cells appear
3. Type III lesion (pre-atheroma)- Small pools of extracellular
form within the vessel wall
4. Type IV lesion (atheroma) - Macrophage foam cells form
core (consisting of dead cells and extracellular lipids)
5. Type V lesion (fibroatheroma)- The necrotic core becomes encased by a
cap
6. Type VI l lesion (complicated lesion)- The fibrous thickening may reduce blood flow
Atheroma may break down, causing a
, fissure or haematoma
Risk factors:
Potentially modifiable: - Smoking - Lipids - Blood pressure - Diabetes - Obesity - Lack of exercise
Not modifiable: Sex, genetic background and
Paradigms (ideas) of pathogenesis:
Inevitable consequence of ageing , The cholesterol hypothesis and Inflammation and immunity
The cholesterol hypothesis:
1904 N.N. Anitschkow – studied advanced plaque in a rabbit fed cholesterol for 124
This lead to the formation of a fibrous
surrounding foam cells, and a necrotic core consisting of cholesterol crystals and calcium
The cholesterol controversy: “the view that raised plasma cholesterol is per se a cause of coronary heart disease is untenable” BMJ 1976
Evidence: in favour of cholesterol as a major etiological factor: Experimental, clinical genetic, epidemiological and interventional
Foam Cells:
LDLs deposit in the
space (intima is the component of the subendothelial layer of vessel wall, between the endothelium and the internal elastic lamina)
The vessel wall consists of many layers (from lumen outwards) Endothelium Subendothelium – Intima Internal elastic lamina Media Adventitia
The LDLs then bind to matrix
Native LDLs are encased with a phospholipid case by apoB
The native LDL is then oxidised and modified to form a
apoB. The modified apoB is recognised as
by macrophages, and is taken up by
receptors to form a macrophages foam cell
The foam cells then release inflammatory mediators (e.g. cytokines, chemokines & oxidised phospholipids) and/or lead to cell death
This damage causes increased recruit and adhesion of
by the endothelium
With normal levels of oxidised LDLS, homeostatic debris disposal occurs
With
levels of oxidised LDLs, this leads to an inflammatory response
Inflammatory basis of atherosclerosis:
Increased levels of activated macrophagic foam cells lead to release of: Free radicals Proteases VSMC growth factors Angiogenic factors Apoptosis
Why is atherosclerosis focal?
The branches and curvatures of blood vessels are more likely to be hot spots for
formation
Blood flow is fast, laminar and shear
At these hot-spots, blood flow is more disorganised.
The endothelium is very sensitive to these changes in blood flow
Terminology of Atherosclerosis:
the gradual loss of lumenal diameter leading to critical reduction in blood flow-
This can be observed by angiography
insufficient blood supply to meet metabolic demands of tissues leads to hypoxic cellular dysfunction-
Typically experienced as pain on exertion, e.g. angina pectoris (heart pain), intermittent claudication (in legs)
the localised area of fat deposition and tissue breakdown (necrosis) within the arterial wall-
Plaque erosion – the breakdown of endothelial lining of the lesion
full rupture of the fibrous cap
Plaque rupture – the breakdown of the fibrous cap of tissue separating plaque from blood
Effects of plaque erosion/rupture:
Plaque growth- Platelet recruitment (involving adhesion and degranulation) and blood coagulation at site - This may lead to silent non-occlusive thrombus and plaque growth
Occlusive thrombosis - Blood coagulation at the site of rupture may lead to an occlusive thrombus and
Embolism- the dislodgment of solid material (e.g. platelet plug, thrombus, cholesterol-rich plaque contents) into the arterial circulation leading to occlusion at distant sites
Effects of arterial occlusion:
occlusion – short ischaemia from an occlusion that spontaneously resolves
Infarction – the death of tissue due to unresolved
Natural history of atherosclerosis:
Development from:
Normal vessel -> intermediate lesion -> advances lesions -> complications (stenosis, rupture etc)
Normal vessel –
Intermediate lesions – 40 yrs
Advanced lesions –
yrs
Complications - >60 yrs
Glasgow Phenomenon – describes the early
of arteries before constriction of the lumen occurs (also known as
positive arterial remodelling)
Window of opportunity for clinical intervention:
Used at the
stage
Secondary prevention, Catheter based interventions, Revascularisation surgery and treatment of heart problems
Window of opportunity for primary prevention:
Used during the development of advanced lesions from intermediate lesions, life-style changes and risk factor management
Pathogenesis:
Atherosclerosis – a chronic
response in the walls of
in large part in reaction to the deposition of
The main cell types involved: Vascular endothelial cells White blood cells (leukocytes) o Particularly monocytes/macrophages Platelets Vascular smooth muscle cells
Macrophages:
White blood cells can injure host tissue if they are activated excessively or inappropriately
In atherosclerosis, the main inflammatory cells are
which are derived from blood
There are many different types , the subtypes are regulated by combinations of
binding to regulatory sequences on DNA. We do not yet understand the regulation.
Two main classes - resident or inflammatory macrophages
Inflammatory macrophages adapted to kill microorganisms
Resident macrophages – normally
o suppressed inflammatory activity o Alveolar resident macrophages (surfactant lipid homeostasis) o Osteoclasts (calcium and phosphate homeostasis) o Spleen (iron homeostasis)
Lipoproteins:
Low density lipoprotein (LDL)-
cholesterol
synthesised in
carries cholesterol from liver to rest of body including arteries
High density lipoprotein (HDL):
cholesterol. It carries cholesterol from ‘peripheral tissues’ including arteries back to liver (=“reverse cholesterol transport”)
Oxidised LDL(s), modified LDL(s):
Due to action of free radicals on LDL (see later)
Families of highly inflammatory and toxic forms of LDL found in vessel walls.
Sub-endothelial trapping of LDL:
Low density lipoproteins (LDL) leak through the
barrier by uncertain mechanisms
LDL is trapped by binding to sticky matrix carbohydrates (proteoglycans) in the sub-endothelial layer
Trapped LDL is susceptible to modification
Modification of trapped LDL:
Best studied modification is
Chemically represents partial burning
LDL becomes oxidatively modified by
Oxidised LDL is phagocytosed by macrophages to form a foam cell - this stimulates chronic inflammation
Familial Hypelipidemia (FH):
Autosomal
genetic disease
Massively elevated cholesterol (20mmol/L)
Failure to clear
from blood
xanthomas (fatty cholesterol lumps visible on skin) and early atherosclerosis
Cholesterol Homeostasis:
The rate limiting enzyme of cholesterol synthesis is
SREBP (sterol response element binding protein)- activated by
cholesterol which activates gene for HMGCoA reductase
If LDL receptor (LDLR) is working properly, increased LDL levels inactivate liver SREBP and reduce cholesterol synthesis- this is
In LDLR-negative patients, macrophages accumulate cholesterol
In atherosclerotic lesions, there is a second LDL receptor - not under feedback control which is called the
receptor since it hoovers up chemically modified LDL
Now known that scavenger receptors are a family of pathogen receptors that ‘accidentally’ bind oxidised LDL
Macrophage Scavenger receptors:
Receptor A:
Expresses CD204, binds to oxidised LDL, binds to
bacteria like Staphylococci and Streptococci
Receptor B: Expresses CD36, binds to oxidised LDL, binds to malaria parasites and binds to dead cells
Macrophages within atherosclerotic plaques:
1. Generate of free radicals that further oxidise
- Macrophage Oxidative enzymes, Can modify native LDL, NADPH Oxidase- superoxide O2-
Myeloperoxidase- HOCl hypochlorous acid (bleach) from ROS + Cl- and HONOO Peroxynitrite
2. Phagocytose/scavenge modified lipoproteins, and become
3. Become activated by modified lipoproteins/free intracellular cholesterol to express/secrete
A. Inflammatory mediators (eg TNFa, IL-1, MCP-1) that recruit more
- Cytokines – protein immune hormones that activate endothelial cell adhesion molecules:
Interleukin-1 upregulates vascular cell
molecule 1 (VCAM1)
VCAM-1 mediates tight
binding
Atherosclerosis is
in mice without IL-1 or VCAM-1
Chemokines - small proteins chemoattractant to monocytes:
Monocyte
protein-1 (MCP-1)
MCP-1 binds to a monocyte G-protein coupled receptor
in MCP-1 or CCR2 deficient mice
B. Chemoattractants and growth factors for Vascular Smooth Muscle Cells (VSMC):
Macrophages release complementary protein growth factors that recruit
and stimulate them to proliferate and deposit extracellular matrix,
their contractile filaments
Platelet derived growth factor- Vascular smooth muscle cell chemotaxis o Vascular smooth muscle cell survival o Vascular smooth muscle cell division (mitosis)
Transforming growth factor beta o Increased
synthesis o Matrix deposition
C. Proteinases that degrade tissue (e.g. the fibrous cap):
Metalloproteinases (=MMPs) o Family of ~28 homologous enzymes o Activate each other by
o Degrades collagen o Catalytic mechanism based on
Vulnerable yet stable plaques have certain characteristics:
Large soft eccentric
-rich necrotic core
Thin fibrous cap o Reduced VSMC and collagen content o Increased VSMC
Infiltrate of activated macrophages expressing MMPs
D. Tissue factor that stimulates coagulation upon contact with blood
Crosstalk between inflammation and coagulation: healing wound need to clot blood and fight infection
Tissue factor (TF) is a 263 amino acid membrane protein expressed on activated
TF initiates the
cascade
Macrophage TF is increased in atherosclerosis
Erosion/rupture of the fibrous cap leads to access of the plasma coagulation cascade to macrophage tissue factor with consequent thrombosis
4. Die by apoptosis – contributing to the lipid-rich core of the plaque
Oxidised LDL derived metabolites are
Macrophage foam cells have protective systems that maintain survival in face of toxic lipid loading
Once overwhelmed, macrophages die via apoptosis
Releases macrophage tissue factor and toxic lipids into the ‘central death zone’ called lipid
Thrombogenic and toxic material accumulates, walled off by the fibrous plaque, until plaque ruptures which causes it to meet blood
SUMMARY:
are the major inflammatory cell type in atherosclerosis
protective functions in the plaque:
Clearing debris (modified lipoproteins, dead cells) o Stimulating “wound healing” response involving
deleterious functions:
Release of free radicals that modify
Recruitment of further monocytes via cytokines and chemokines
Expression of MMPs that may destabilise the
Expression of tissue factor that can stimulate
Structure of Arteries & Veins:
3 layers (except capillaries and venules):
- Endothelium - Basement membrane - Lamina propria (smooth muscle and connective tissue) - Internal elastic membrane
- Smooth muscle cells - External elastic membrane
- Vasa vasorum - Nerves
Vascular endothelium:
Surface separating blood from other tissues, very extensive - Surface area >1000m2, Weight >100g
Formed by a monolayer of cells, one cell deep
-mechanism at cell junctions which stops further cell growth
Very flat cells, about 1-2 micrometres thick and 10-20 micrometers in diameter, cells have a
proliferation rate (unless new vessels are required)
Endothelial cells:
Regulates:
Thrombosis & haemostasis - Antithrombotic factors - Procoagulant factors
Angiogenesis - Growth factors - Matrix proteins
Vascular tone & permeability - Vasodilator factors - Vasoconstricting factors
Inflammation - Adhesion molecules - Inflammatory mediators
Regulation of endothelial homeostasis:
At rest, there is a homeostatic balance between different factors: o Anti-inflammatory & pro-inflammatory o Anti-thrombotic & pro-thrombotic o Anti-proliferative & pro-angiogenic
Infection, injury etc, may temporarily tip the balance leading to an
endothelium, but then will return to its resting state
The endothelium may be activated by: o Smoking o Viruses o Mechanical stress o Inflammation o High blood pressure o Oxidised LDLs o High glucose
This activation leads to: o Thrombosis o Senescence o Increased permeability o Leukocyte recruitment
Chronic activation of the endothelium may also lead to
Role of the endothelium in atherosclerosis:
Vascular permeability-
The endothelium regulates the flux of fluids and molecules from blood to tissues and vice versa
Increased permeability results in leakage of
through the junctions into the subendothelial space:
This causes lipoprotein trapping and
modification
The modified LDLs may then be taken up by macrophages forming foam cells, which causes chronic inflammation
Leukocyte recruitment:
Contact inhibition at endothelial junctions regulates the movement of
from blood into tissues
The activation of the endothelium causes the leukocyte
o Capture o Rolling o Arrest o Adhesion o Intravascular crawling o Paracellular and transcellular transmigration
This involves: o selectins (E, P & L-selectins) o chemoattractants (MCP-1, IL-8) o ICAM-1, VCAM-1 o Integrins (LFA-1, VLA-4)
Vessel differences:
Capillary – endothelial cells surrounded by basement membrane and pre-capillary cells known as
Post-capillary venule – structure similar to capillaries but more pericytes
Artery – 3 thick layers rich in cells and extracellular matrix
Recruitment of blood leukocytes into tissues takes place normally during
In atherosclerosis, leukocytes adhere to the activated endothelium of
arteries and get stuck in the subendothelial space (in the smooth muscle layer)
Newly formed post-capillary venules at the base of developing lesions provide a further portal for leukocyte entry
Senescence:
Replicative senescence: the limited proliferative capacity of human cells in culture
In response to stress and damage,
senescence locks cells in a permanent form of growth arrest
This is linked to progressive shortening and dysfunction of
Senescent cells have a distinct morphology and acquire specific markers, e.g. beta-gal
senescence is telomere independent
In atherosclerotic lesions, vascular cells have morphological features of senescence
Can be induced by CV risk factors, such as oxidative stress, that induced increased cell replicatio n to replace dead or damaged cells
Angiogenesis: Formation of new blood vessels by sprouting from pre-existing vessels
Cascade of events lead by specialised endothelial tip cells
Cascade involves:
Production of
factor
Release of factor
Extracellular receptor binding which causes intracellular
Extracellular activation
Extracellular
Directional migration, Extracellular matrix remodelling, Tube formation, loop formation and vascular stabilization
The
paradox: Angiogenesis promotes plaque growth, but can be used therapeutically to induce new formation in ischaemic tissues
Pathogenesis of Atherosclerosis: Inflammation Model
Endothelial dysfunction leads to: increased endothelial
Leukocyte migration and adhesion
This leads to fatty-streak formation and
cell formation
There is then a formation of an advanced, complicated lesion of atherosclerosis
Macrophage accumulation & formation of a necrotic core, angiogenesis also occurs
Potassium hypothesis:
The membrane is more
to potassium than anything else
The potassium ions can move down their concentration gradient carrying
with it.
As it moves down the concentration gradient, there is a build up of positive charge in the
chamber and the
chamber becomes increasingly negative
Electrical gradient
concentration gradient
Eventually you get to a point where the electrical gradient is
to the concentration gradient
At this point, the ion is in
Ions can move back and forth randomly through the channel but there is
net movement of ions
Resting Membrane Potential :
This can be predicted using the
Potassium Concentrations: Inside = 120 mM Outside =
If you plug these values into the Nernst equation then you get an equilibrium potential of around
This is very near the resting membrane potential of a ventricular myocyte K+ concentration is maintained by the sodium-potassium pump
K+ concentration is maintained by the sodium-potassium pump
Changing the permeability of the membrane to sodium:
Membrane potential will change based on the relative
to different ions. The Nernst equation can be used with Sodium to give an equilibrium potential of +66 mV
During the upstroke, when the membrane is only permeable to
the potential across the membrane will equal the equilibrium potential of
The resting membrane potential is better calculated using the
equation - this takes into account the relative permeabilities of the membrane to different ions
Nerve action potentials last about
Cardiac Action Potential (lasts around 100-200ms):
UPSTROKE - exactly the same as in a nerve - caused by the opening of
channels. Sodium channels then inactivate so the membrane potential starts to recover and repolarise slightly
As the sodium channels inactivate, there is a brief increase in the permeability to
(due to the opening of the transient outward channels)
This brief increase in potassium permeability (and subsequent efflux of potassium)
the membrane giving rise to this characteristic notch
The sodium channels inactivate quickly and can NOT be opened for a long period of time This is the
refractory period
Cardiac muscle has a
absolute refractory period meaning that you can't re-stimulate the muscle for a long time so the cardiac muscle will not
KEY FEATURE: there is an increase in permeability to
and these calcium channels remain open for a long time which is why they are called
L
This influx of calcium just about balances the efflux of potassium thus keeping the membrane depolarised at the plateau value (around 0 mV)
Repolarisation does eventually occur due to the eventual inactivation of the L-type calcium channels and the opening of a another subtype of
Refractory Period:
As the membrane repolarises (becomes more negative) more
channels become available
The long absolute refractory period prevents tetany
General Notes on Cardiac Action Potential :
Cardiac action potential is
Duration of action potential determines the duration of the contraction of the heart
Long, slow contraction is necessary to produce an effective pump
At rest, membrane potential is dictated by
Absolute Refractory Period = time during which no action potential can be initiated regardless of stimulus intensity
Relative Refractory Period = period after absolute refractory period where an action potential can only be elicited with stimulus strength that is larger than normal
Full Recovery Time = the time at which a normal action potential can be elicited with normal stimulus
Muscle Excitation and Tetanus:
Skeletal Muscle - repolarisation occurs very
in the contraction and is very short meaning that re-stimulation can take place very soon after the first action potential
This makes re-stimulation and summation of contraction possible
Cardiac Muscle - has a long refractory period meaning that the muscle can't be re-stimulated until the process of contraction is well underway - so cardiac muscle can NOT be tetanised
The electrical properties of the heart are
The heart has its own independent electrical impulse generation and propagation system
There is a specialised conduction system in the heart The myogenic nature of the nerve impulses mean that the heart can keep beating independently even after being separated from its
The internal electrical activity is modulated by sympathetic and parasympathetic nerves
Phases of the Action Potential:
Phase 1 - early
- caused by inactivation of sodium channels (meaning there is no further depolarisation) and the
potassium current starting
Phase 2 - plateau - partly due to
influx which keeps the membrane potential more positive
Calcium influx is required to trigger calcium release from intracellular stores (Calcium Induced Calcium Release) , calcium is also required for
Increase in calcium permeability takes place rapidly and is
than the influx of sodium
Calcium permeability can be inhibited by a variety of drugs used for anti-hypertensive therapy - calcium channel antagonists are used such as: Nitrendipine, Nisoldipine
These work by blocking
by binding to the L-type calcium channels
These drugs also work in
(which governs vessel pressure) - smooth muscle also has L-type calcium channels
Phase 3 = Repolarisation
A small (normal) potassium current starts to activate towards the end of the plateau and this begins
This is only a slight increase in permeability to potassium
There is a weird potassium current in cardiac tissue called
which switches off during depolarisation but as the membrane gets gradually more and more repolarised (due to the efflux of potassium via the normal channel) the channel switches on
This IK1 current is large and flows during
IK1 stabilises the resting membrane potential and reduces the risk of
Different parts of the heart have different action potential shapes This is because of different
Sinoatrial Node: